GCA Altium advised Hohnhaus & Jansenberger and Cathay Capital on an acquisition financing for medifa healthcare group
medifa’s product and service portfolio covers all operating room requirements including modular wall, door, ceiling and cabinet systems for the turnkey operating room, operating tables, table accessories and operating lights. medifa is also the owner of one of the largest German OEM suppliers in the medical technology sector.
With Cathay Capital and its global resources and deeply rooted local business development know-how, medifa has found the ideal partner to accelerate its growth in foreign markets. Thanks to Cathay Capital’s support, medifa has established a strategic partnership in China with a leading provider of medical gas and air purification systems for operating rooms. This partnership notably presents medifa the opportunity to obtain regulatory approvals in China for all relevant products, set up showrooms, and provide a network for local distribution and installation as well as additional customer services on the ground.
Hohnhaus & Jansenberger is an operationally driven mid-market investment firm based in Munich. Dr. Wolfgang Hohnhaus, Managing Partner at H&J and co-CEO at medifa, said: “We are pleased to remain a significant shareholder in medifa and to continue to support its growth trajectory. We are confident in the ongoing added value generated by our longstanding and trust-based partnership with medifa and Cathay Capital, and we are delighted to welcome on board Yielco as a new co-investor and partner.”
Thorsten Weber, Managing Director at GCA Altium, commented: “We are convinced that the consortium led by H&J and Cathay Capital is the ideal partner for medifa. Together with the management team they will lead the group into its next growth phase. The financing structure, based on a comprehensive selection process involving several financing options, is a perfect fit and supports the company’s plans to further grow its business.”
GCA Altium advised on a tailor-made debt financing including all commercial aspects of the financing transaction. The new financing structure provides medifa with a high degree of flexibility in its daily business and will strengthen its growth strategy.
The transaction closed on the 30th June 2021. The parties agreed that no further details of the transaction would be disclosed.